Epocrates vs PrecisePK
PrecisePK is dosing software for a hospital pharmacy department. It individualizes doses from a single blood-level draw, runs vancomycin AUC24 dosing that the vendor calls compliant with the 2020 ASHP/IDSA guidelines, and does busulfan AUC targeting. A customer testimonial on the homepage mentions neonatal, pediatric and adult models. The interface comes in English, Spanish, Chinese, Thai and Korean, and the homepage advertises a 60-day free trial whose form page gives no length or terms.
Epocrates sells an individual plan at $24.99 per month and a group plan for teams and residents, with student access through a student email. Its content is drug information, interaction checks, calculators and disease guidance. It has belonged to athenahealth since 2013.
A pharmacy department adjusting vancomycin from a measured level and a clinician looking up an interaction are separate buyers. The pharmacy weighs PrecisePK's guideline claim and trial, the clinician Epocrates' monthly price.
Drug info · Reviewed November 2, 2026

Epocrates
by Epocrates (athenahealth) · founded 1998
Drug reference app with interaction checks, calculators, disease guidance and a beta AI Assist.

PrecisePK
by PrecisePK
Bayesian model-informed precision dosing software that calculates individualized drug regimens from serum levels, including vancomycin.
When to pick each one
Epocrates
- Individual plan at $24.99 per month
- Student access through a student email
PrecisePK
- Vancomycin AUC24 and busulfan AUC dosing
- Interface in five languages
- 60-day free trial advertised
Score
Each row shows points earned of points available under the published rubric.
Epocrates
74of 100
PrecisePK
55of 100
| Dimension | Epocrates | PrecisePK | Difference |
|---|---|---|---|
| EHR integrations (count) | 0 / 4.2 | 1.3 / 4.2 | -1.3 |
| Top-3 EHR coverage (Epic / Oracle / Athena) | 0 / 2.4 | 1.7 / 2.4 | -1.7 |
| Peer-reviewed papers | 14.7 / 21 | 21 / 21 | -6.3 |
| RCT / meta-analysis / systematic review | 3 / 6 | 3 / 6 | 0 |
| Funding & adoption signal | 15.6 / 15.6 | 3.9 / 15.6 | +11.7 |
| Pricing transparency | 6 / 6 | 3 / 6 | +3 |
| Years in market | 6 / 6 | 0 / 6 | +6 |
Scroll horizontally to see every column.
Pricing
Epocrates
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| epocrates+, monthly | $24.99 | n/a | Cancel anytime. |
| epocrates+, yearly | n/a | $179.99 | The page says Save 40% when subscribing annually. Trial and refund terms are not stated. |
PrecisePK
| Tier | Monthly | Annual | Notes |
|---|---|---|---|
| Enterprise | n/a | n/a | No public price. Homepage advertises "Free for 60 days" trial; the trial page gives no length or terms. |
Evidence
Epocrates
Peer-reviewed
4 PubMed records name Epocrates.
- Retrospective cohort observation on psychotropic drug-drug interaction and identification utility from 3 databases: Drugs.com®, Lexicomp®, and Epocrates®. (opens in new tab)
- Agreement of Different Drug-Drug Interaction Checkers for Proton Pump Inhibitors. (opens in new tab)
- Assessing accuracy and completeness of drug information in mobile apps compared with Micromedex®: An AI-based study in Thai online communities. (opens in new tab)
PrecisePK
Peer-reviewed
5 PubMed records name PrecisePK.
- Predictive Performance of Bayesian Dosing Software for Vancomycin in Intensive Care Unit Patients. (opens in new tab)
- Model-Informed Precision Dosing of Vancomycin in Vietnamese Children: Innovative Midpoint Concentration Monitoring Using 2 Bayesian Programs. (opens in new tab)
- [Free online software tools for precision dosing of vancomycin, and other drugs]. (opens in new tab)
Compliance and integrations
Documented from each vendor’s own pages.
| Spec | Epocrates | PrecisePK |
|---|---|---|
| Free tier | ||
| HIPAA | ||
| SOC 2 Type II | ||
| EHR integrations | Not specified | Epic, Cerner |
| Founded | 1998 | n/a |
| HQ | US | US |
Scroll horizontally to see both columns.
Common questions
Open the full drug info comparison
Drug references (Lexidrug, Micromedex, Epocrates) and interaction checkers (Drugs.com, Medscape). Built for the clinician at the point of care.
